Upload
doanliem
View
215
Download
0
Embed Size (px)
Citation preview
Copyright © 2006 by Mosby, Inc.Slide 1
Chapter 17Chapter 17 Tuberculosis Tuberculosis
Figure 17-1. Tuberculosis. A, Early primary infection. B, Cavitation of a caseous tubercle and new Figure 17-1. Tuberculosis. A, Early primary infection. B, Cavitation of a caseous tubercle and new primary lesions developing. C, Further progression and development of cavitations and new primary primary lesions developing. C, Further progression and development of cavitations and new primary
infections. Note the subpleural location of some of these lesions. D, Severe lung destruction caused by infections. Note the subpleural location of some of these lesions. D, Severe lung destruction caused by tuberculosis. tuberculosis.
A
C
B
D
Copyright © 2006 by Mosby, Inc.Slide 2
Anatomic Alterations of the LungsAnatomic Alterations of the Lungs
(Three categories)(Three categories) Primary tuberculosisPrimary tuberculosis
Primary infection stagePrimary infection stage
Postprimary tuberculosisPostprimary tuberculosis Secondary or reinfection TBSecondary or reinfection TB
Disseminated tuberculosisDisseminated tuberculosis Extrapulmonary TBExtrapulmonary TB
Copyright © 2006 by Mosby, Inc.Slide 3
Anatomic Alterations of the LungsAnatomic Alterations of the Lungs(Mainly Primary TB)(Mainly Primary TB)
Alveolar consolidationAlveolar consolidation Alveolar-capillary destructionAlveolar-capillary destruction Caseous tubercles or granulomasCaseous tubercles or granulomas Fibrosis and secondary calcification of the Fibrosis and secondary calcification of the
lung parenchymalung parenchyma Distortion and dilation of the bronchiDistortion and dilation of the bronchi Increased bronchial airway secretionsIncreased bronchial airway secretions
Copyright © 2006 by Mosby, Inc.Slide 4
EtiologyEtiology
In human, TB primarily caused by In human, TB primarily caused by Mycobacterium tuberculosisMycobacterium tuberculosis
OthersOthers Mycobacterium bovisMycobacterium bovis Mycobacterium ulceransMycobacterium ulcerans Mycobacterium kansasiiMycobacterium kansasii Mycobacterium avium-intracellulareMycobacterium avium-intracellulare
Highly aerobic organismsHighly aerobic organisms
Copyright © 2006 by Mosby, Inc.Slide 5
DiagnosisDiagnosis
Intradermal tuberculin skin testingIntradermal tuberculin skin testing Mantoux testMantoux test Injection of purified protein derivative (PPD)Injection of purified protein derivative (PPD)
• Wheal <5 mm: negativeWheal <5 mm: negative
• Wheal 5 mm to 9 mm: considered suspiciousWheal 5 mm to 9 mm: considered suspicious
• Wheal 10 mm or greater: positiveWheal 10 mm or greater: positive
Copyright © 2006 by Mosby, Inc.Slide 6
DiagnosisDiagnosis
Acid-fast stain and sputum cultureAcid-fast stain and sputum culture Ziehl-Neelsen stainZiehl-Neelsen stain
• Reveals bright red acid-fast bacilli against a blue backgroundReveals bright red acid-fast bacilli against a blue background
Fluorescent acid-fast stainFluorescent acid-fast stain• Reveals luminescent yellow-green bacilli against a dark brown Reveals luminescent yellow-green bacilli against a dark brown
backgroundbackground
A culture is necessary to differentiate A culture is necessary to differentiate M. tuberculosisM. tuberculosis form other acid-fast organismsform other acid-fast organisms• Results take as long as 6 to 8 weeksResults take as long as 6 to 8 weeks
Copyright © 2006 by Mosby, Inc.Slide 7
DiagnosisDiagnosis
Identification of Identification of MycobacteriumMycobacterium species species Polymerase chain reaction (PCR)Polymerase chain reaction (PCR)
• Quick identification of organisms in expectorated or Quick identification of organisms in expectorated or bronchoscopically obtained sputumbronchoscopically obtained sputum
Deoxyribonucleic acid (DNA) probeDeoxyribonucleic acid (DNA) probe
Copyright © 2006 by Mosby, Inc.Slide 8
Nontuberculosis MycobacteriaNontuberculosis Mycobacteria
Mycobacterial infection caused by species Mycobacterial infection caused by species other than other than M. tuberculosisM. tuberculosis are called are called nontuberculosis mycobacteria (NTM)—also nontuberculosis mycobacteria (NTM)—also called:called: Mycobacteria other than tuberculosis (MOTT)Mycobacteria other than tuberculosis (MOTT) Atypical mycobacterial infectionAtypical mycobacterial infection
Found in soil and waterFound in soil and water
Copyright © 2006 by Mosby, Inc.Slide 9
Overview of the Cardiopulmonary Overview of the Cardiopulmonary Clinical Manifestations Associated Clinical Manifestations Associated
with TUBERCULOSISwith TUBERCULOSIS
The following clinical manifestations result from The following clinical manifestations result from the pathophysiologic mechanisms caused (or the pathophysiologic mechanisms caused (or activated) by activated) by Alveolar ConsolidationAlveolar Consolidation (see (see Figure 9-8), and Figure 9-8), and Increased Alveolar-Capillary Increased Alveolar-Capillary Membrane ThicknessMembrane Thickness (see Figure 9-9)—the (see Figure 9-9)—the major anatomic alterations of the lungs major anatomic alterations of the lungs associated with tuberculosis (see Figure 17-1). associated with tuberculosis (see Figure 17-1).
Copyright © 2006 by Mosby, Inc.Slide 10
Figure 9-8. Alveolar consolidation clinical scenario.Figure 9-8. Alveolar consolidation clinical scenario.
Copyright © 2006 by Mosby, Inc.Slide 11
Figure 9-9. Increased alveolar-capillary membrane thickness clinical scenario.Figure 9-9. Increased alveolar-capillary membrane thickness clinical scenario.
Copyright © 2006 by Mosby, Inc.Slide 12
Clinical Data Obtained at theClinical Data Obtained at the Patient’s Bedside Patient’s Bedside
Vital signsVital signs Increased respiratory rateIncreased respiratory rate Increased heart rate, cardiac output, Increased heart rate, cardiac output,
blood pressureblood pressure
Copyright © 2006 by Mosby, Inc.Slide 13
Clinical Data Obtained at the Clinical Data Obtained at the Patient’s BedsidePatient’s Bedside
Chest pain/decreased chest expansionChest pain/decreased chest expansion CyanosisCyanosis Digital clubbingDigital clubbing Peripheral edema and distentionPeripheral edema and distention
Distended neck veinsDistended neck veins Pitting edemaPitting edema Enlarged and tender liverEnlarged and tender liver
Copyright © 2006 by Mosby, Inc.Slide 14
Digital Clubbing
Figure 2-46. Digital clubbing.Figure 2-46. Digital clubbing.
Copyright © 2006 by Mosby, Inc.Slide 15
DistendedDistendedNeck VeinsNeck Veins
Figure 2-48. Distended neck veins (Figure 2-48. Distended neck veins (arrowsarrows).).
Copyright © 2006 by Mosby, Inc.Slide 16
Figure 2-47. Pitting edema. From Bloom A, Ireland J: Figure 2-47. Pitting edema. From Bloom A, Ireland J: Color atlas of diabetesColor atlas of diabetes, ed 2,, ed 2,London, 1992, Mosby-Wolfe.London, 1992, Mosby-Wolfe.
Copyright © 2006 by Mosby, Inc.Slide 17
Clinical Data Obtained at the Clinical Data Obtained at the Patient’s BedsidePatient’s Bedside
Cough, sputum production, and hemoptysisCough, sputum production, and hemoptysis Chest assessment findingsChest assessment findings
Increased tactile and vocal fremitusIncreased tactile and vocal fremitus Dull percussion noteDull percussion note Bronchial breath soundsBronchial breath sounds Crackles, rhonchi, and wheezingCrackles, rhonchi, and wheezing Pleural friction rubPleural friction rub Whispered pectoriloquyWhispered pectoriloquy
Copyright © 2006 by Mosby, Inc.Slide 18
Figure 2-11. Figure 2-11. A short, dull, or flat percussion note is typically produced over areas A short, dull, or flat percussion note is typically produced over areas of alveolar consolidation.of alveolar consolidation.
Copyright © 2006 by Mosby, Inc.Slide 19
Figure 2-16. Figure 2-16. Auscultation of bronchial breath sounds over a consolidated lung Auscultation of bronchial breath sounds over a consolidated lung unit.unit.
Copyright © 2006 by Mosby, Inc.Slide 20
Figure 2-19. Figure 2-19. Whispered voice sounds auscultated over a normal lungWhispered voice sounds auscultated over a normal lungare usually faint and unintelligible.are usually faint and unintelligible.
Copyright © 2006 by Mosby, Inc.Slide 21
Clinical Data Obtained from Clinical Data Obtained from Laboratory Tests and Special Laboratory Tests and Special
ProceduresProcedures
Copyright © 2006 by Mosby, Inc.Slide 22
Pulmonary Function Study: Pulmonary Function Study: Expiratory Maneuver FindingsExpiratory Maneuver Findings
FVC FEVT FEF25%-75% FEF200-1200
N or N or N
PEFR MVV FEF50% FEV1% N N or N N or
Copyright © 2006 by Mosby, Inc.Slide 23
Pulmonary Function Study: Pulmonary Function Study: Lung Volume and Capacity Findings Lung Volume and Capacity Findings
VT RV FRC TLC N or
VC IC ERV RV/TLC% N
Copyright © 2006 by Mosby, Inc.Slide 24
Arterial Blood GasesArterial Blood Gases
Mild to Moderate TuberculosisMild to Moderate Tuberculosis Acute alveolar hyperventilation with Acute alveolar hyperventilation with
hypoxemiahypoxemia
pH PaCO2 HCO3- PaO2
(Slightly)
Copyright © 2006 by Mosby, Inc.Slide 25
Time and Progression of Disease
100
50
30
80
0
PaCO2
10
20
40
Alveolar Hyperventilation
60
70
90 Point at which PaO2 declines enough to stimulate peripheral oxygen receptors
PaO2
Disease OnsetPa
O2 o
r PaC
O2
Figure 4-2. PaO2 and PaC02 trends during acute alveolar hyperventilation.
Copyright © 2006 by Mosby, Inc.Slide 26
Arterial Blood GasesArterial Blood Gases
Extensive Tuberculosis with PulmonaryExtensive Tuberculosis with PulmonaryFibrosisFibrosis Chronic ventilatory failure with hypoxemiaChronic ventilatory failure with hypoxemia
pH PaCO2 HCO3- PaO2
Normal (Significantly)
Copyright © 2006 by Mosby, Inc.Slide 27
Time and Progression of Disease
100
50
30
80
0
PaO2
10
20
40
Alveolar Hyperventilation
60
70
90Point at which PaO2 declines enough to stimulate peripheral oxygen receptors
PaCO 2
Chronic Ventilatory FailureDisease Onset
Point at which disease becomes severe and patient begins to become fatigued
Pa0 2
or P
aC0 2
Figure 4-7. PaO2 and PaCO2 trends during acute or chronic ventilatory failure.
Copyright © 2006 by Mosby, Inc.Slide 28
Acute Ventilatory Changes on Acute Ventilatory Changes on Chronic Ventilatory FailureChronic Ventilatory Failure
Acute alveolar hyperventilation on chronic Acute alveolar hyperventilation on chronic ventilatory failureventilatory failure
Acute ventilatory failure on chronic ventilatory Acute ventilatory failure on chronic ventilatory failurefailure
Copyright © 2006 by Mosby, Inc.Slide 29
Oxygenation IndicesOxygenation Indices
QS/QT DO2 VO2 C(a-v)O2
Normal Normal
O2ER SvO2
Copyright © 2006 by Mosby, Inc.Slide 30
Hemodynamic Indices Hemodynamic Indices (Severe Tuberculosis)(Severe Tuberculosis)
CVP CVP RAPRAP PAPA PCWPPCWP
NormalNormal
COCO SVSV SVISVI CICI
NormalNormal NormalNormal NormalNormal Normal Normal
RVSWIRVSWI LVSWILVSWI PVRPVR SVRSVR
NormalNormal NormalNormal
Copyright © 2006 by Mosby, Inc.Slide 31
Abnormal Laboratory TestsAbnormal Laboratory Testsand Proceduresand Procedures
Positive tuberculosis skin test (PPD)Positive tuberculosis skin test (PPD) Positive acid-fast bacillus stain of sputumPositive acid-fast bacillus stain of sputum
and sputum cultureand sputum culture
Copyright © 2006 by Mosby, Inc.Slide 32
Radiologic FindingsRadiologic Findings
Chest radiographChest radiograph Increased opacityIncreased opacity Ghon’s complexGhon’s complex Cavity formationCavity formation Pleural effusionPleural effusion Calcification and fibrosisCalcification and fibrosis Retraction of lung segments or lobeRetraction of lung segments or lobe Right ventricular enlargementRight ventricular enlargement
Copyright © 2006 by Mosby, Inc.Slide 33
Figure 17-2. Cavitary reactivation TB showing a left upper lobe cavity and localized pleural thickening Figure 17-2. Cavitary reactivation TB showing a left upper lobe cavity and localized pleural thickening (arrows). (arrows). (From Armstrong P et al: (From Armstrong P et al: Imaging of diseases of the chest,Imaging of diseases of the chest, ed 2, St. Louis, 1995, Mosby.) ed 2, St. Louis, 1995, Mosby.)
Copyright © 2006 by Mosby, Inc.Slide 34
General Management of General Management of TuberculosisTuberculosis
Pharmacologic agents Pharmacologic agents Consists of 2 to 4 drugs for 6 to 12 monthsConsists of 2 to 4 drugs for 6 to 12 months
First-line agents (first 9 months)First-line agents (first 9 months)• Isoniazid (INH) and rifampin (Rifadin)Isoniazid (INH) and rifampin (Rifadin)
• INH most effectiveINH most effective
Often supplemented with:Often supplemented with:• EthambutolEthambutol
• StreptomycinStreptomycin
• Pyrazinamide Pyrazinamide
Copyright © 2006 by Mosby, Inc.Slide 35
General Management of General Management of TuberculosisTuberculosis
Respiratory care treatment protocolsRespiratory care treatment protocols Oxygen therapy protocolOxygen therapy protocol Bronchopulmonary hygiene therapy protocolBronchopulmonary hygiene therapy protocol Hyperinflation therapy protocolHyperinflation therapy protocol Mechanical ventilation protocolMechanical ventilation protocol
Copyright © 2006 by Mosby, Inc.Slide 36
ReviewReview
The protective cell wall that surrounds and The protective cell wall that surrounds and encases the TB bacilli is called -?encases the TB bacilli is called -? Tubercle or granulomaTubercle or granuloma
What is primary TB?What is primary TB? Reaction following first exposure to pathogenReaction following first exposure to pathogen
• Inflammation leading to alveolar consolidationInflammation leading to alveolar consolidation
• Formation of tubercleFormation of tubercle
• Fibrosis and calcification, development of bronchiectasisFibrosis and calcification, development of bronchiectasis
Copyright © 2006 by Mosby, Inc.Slide 37
What is postprimary TB?What is postprimary TB? Reactivation of TB after initial infection has been Reactivation of TB after initial infection has been
controlledcontrolled
What is dissemminated TB?What is dissemminated TB? Infection that spreads to sites outside the lung via Infection that spreads to sites outside the lung via
pulmonary lymphatic system or bloodstreampulmonary lymphatic system or bloodstream
The presence of numerous small tubercles The presence of numerous small tubercles scattered throughout the body is called - ?scattered throughout the body is called - ? Miliary tuberculosisMiliary tuberculosis
Copyright © 2006 by Mosby, Inc.Slide 38
How long can TB bacillus remain suspended How long can TB bacillus remain suspended in the air after a sneeze or a cough?in the air after a sneeze or a cough? Several hoursSeveral hours
What is a Ghon’s complex?What is a Ghon’s complex? Combination of tubercles and hilar Combination of tubercles and hilar
lymphadenopathy seen on CXRlymphadenopathy seen on CXR
Typical ABG’s from a patient with extensive Typical ABG’s from a patient with extensive TB and fibrosis would be describe as - ?TB and fibrosis would be describe as - ? Chronic Ventilatory failure and hypoxemiaChronic Ventilatory failure and hypoxemia
Copyright © 2006 by Mosby, Inc.Slide 39
What hemodynamic indices reflect right-side What hemodynamic indices reflect right-side heart failure in a patient with advanced TB?heart failure in a patient with advanced TB? Increased CVPIncreased CVP Increased RAPIncreased RAP Increased mean PAIncreased mean PA Increased PVRIncreased PVR Increased RVSWIIncreased RVSWI
What respiratory care treatments/protocols are What respiratory care treatments/protocols are used for TB?used for TB? O2 TherapyO2 Therapy BHTBHT Hyperinflation TherapyHyperinflation Therapy
Copyright © 2006 by Mosby, Inc.Slide 40
True or FalseTrue or False Pleural space complications such as Pleural space complications such as
empyema and pneumothorax are common in empyema and pneumothorax are common in patients with tuberculosis.patients with tuberculosis. TrueTrue
A positive reaction to the tuberculin skin test A positive reaction to the tuberculin skin test confirms that a patient has active tuberculosisconfirms that a patient has active tuberculosis FalseFalse
Tuberculosis commonly develops in the Tuberculosis commonly develops in the apices of the lungsapices of the lungs TrueTrue
Copyright © 2006 by Mosby, Inc.Slide 41
Classroom DiscussionClassroom DiscussionCase Study: TuberculosisCase Study: Tuberculosis